product portfolio
MEDICINES
- COVID-19: IBH61, IBH62
- Oncology: IBH1, IBH9, IBH13.1, IBH13.2, IBH26
- Metabolic disorders: IBH5, IBH45.1, IBH45.2, IBH 45.3
- Neurological diseases: IBH18, IBH54
- Immunological diseases: IBH15, IBH39, IBH43, IBH44
- Infectious diseases: IBH7, IBH10, IBH24
- Cardiovascular diseases: IBH25
- Ophthalmological diseases: IBH25, IBH27, IBH38
- Regenerative medicine: IBH28
- Painkillers, anti-inflammatory: IBH19
TECHNOLOGIES
- Technology of thermogenetic stimulation of heart cells (IBH14.1)
- Technology of thermogenetic stimulation of insulin-producing cells (IBH14.2)
- Evaluation of drug effect using the optical bioimaging platform (IBH33)
- Microfluidic antibiotic screening technology: a versatile platform for streaming antibiotic searches from any microbiota source (IBH35)
SERVICES
Adeno-Associated Viruses (AAV) for Laboratory Purposes (IBH34)
TECHNOLOGIES OF PHARMACEUTICAL SUBSTANCES PRODUCTION (IBH32)
PRODUCTION OF ENZYMES: SITE-SPECIFIC PROTEINASES (IBH3, IBH4)
Full-Cycle Biological Testing Center & Complex Preclinical Studies (IBH36)
Наработка аденоассоциированных вирусов, AAV (IBH34)
технологии Производства биофармацевтических субстанций (IBH32)
комплексные ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ (IBH36)
LICENSES& CERTIFICATES
FOR THE PRODUCTION OF MEDICINES
№ 11719-ЛС-П of 25/06/2012
(VALIDITY PERIOD: UNLIMITED)
FOR STUDIES RELATED TO THE USE OF PATHOGENS OF INFECTIOUS DISEASES OF GROUPS III-IV PATHOGENICITY
(VALIDITY PERIOD: UNLIMITED)
CONTACT us
On cooperation issues please contact the head of NTI Center project department
Sergey Semenov
Sergey Semenov